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Polyunsaturated fatty acids (PUFAs) are widely 
known to possess antitumor activity [1–5] since Na­
kahara reported their suppuressive effect against the 
growth of tumor cells implanted in mice [6]. The PUFAs 
inhibit either the DNA synthesis [2] or proliferation of 
tumor cells [1, 3, 4]. Hyperthermia is receiving atten­
tion as effective mean in combined cancer treatment. 
Exposure of cultured tumor cells to temperatures 
above 41 °C results in inhibition of the DNA synthesis 
[7, 8] and proliferation of tumor cells [9, 10]. Com­
bined effect of PUFAs and hyperthermia has been first 
demonstrated by Kageyama et al. [11]. Oleic acid and 
linoleic acid (at the concentration of 300 μM) decrease 
DNA synthesis in Ehrlich ascites tumor (EAT) cells by 
42.2% and 25.2% respectively upon 19 h culturing 
at 37 °C, and by 17.2 and 8.4% at 42 °C compared to 
EAT cells treated in the absence of fatty acid. The cy­
totoxic activities of fatty acids are shown to augment 
according to the increase in the number of double 
bonds especially in PUFAs consisting of more than 
18 carbon atoms [2, 12]. Therefore, inhibitory activi­
ty of eicosapentaenoic acid (EPA, 20 : 5, n­3) and 
docosahexaenoic acid (DHA, 22 : 6, n­3), possessing 
5 and 6 double bonds, respectively, on either the DNA 
synthesis or tumor cell growth are stronger than those 
of other fatty acids such as gamma­linoleic acid (18 : 2, 
n­6) and arachidonic acid (20 : 4, n­6).
In the present study, in order to exceed beyond 
the combined effect of oleic acid or linoleic acid and 
hyperthermia [11] we used EPA and DHA. A combined 
effect of EPA or DHA and hyperthermia on tumor cells 
seems not to be demonstrated yet. We studied whether 
an inhibitory effect of EPA or DHA on the DNA synthesis 
in tumor cells is markedly enhanced by a combination 
with hyperthermia. Furthermore, the relationship bet­
ween the inhibitory activity of the fatty acids and their 
intracellular accumulation was investigated.
MATERIALS AND METHODS 
Cell culture. Ehrlich ascites tumor cells were 
obtained from female ICR mice with tumor trans­
plants. After washing, cells were suspended in Eagle’ 
minimum essential medium (MEM, Nakarai Tesque, 
Kyoto, Japan), supplemented with 10% fetal bovine 
serum (FBS, Gibco Laboratory, USA) and maintained 
by culturing in a humidified atmosphere of 5% CO2 
at 37 °C. 
Hyperthermic treatment. The cells were sus­
pended in MEM with 10% FBS. EPA and DHA (Sigma 
Chemical Co. St. MO) were separately sonicated and 
dispersed in the culture medium at various concen­
trations. The cell suspension and a suspension con­
taining the test substance were mixed in a glass tube 
(14 mm i.d. x 40 mm); the total volume was 1 ml, which 
contained 10 or 1 x 104 cells for 20­ or 96 h culturing 
after the heat treatment, respectively. Cells in a tightly 
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stopped tube were heated, at 37 °C or 42 °C controlled 
within ± 0.05 °C for 1 h in a water bath (Model C­650, 
Taiyo Scientific Industrial Co., Ltd., Japan) [11].
Assay of DNA synthesis. DNA synthesis was 
assayed by monitoring of [3H]­thymidine (0.74–
1.1 TBq/mmol, Amersham Japan, Tokyo) incorporated 
into the acid­insoluble fraction of cells. After heat treat­
ment, cells were cultured at 37 °C for 19 h, nearly equal 
to the cell cycle period, or 96 h for long­term culture, 
and labeled with 1 μCi (37 kBq) of [3H]­thymidine for 
1 h. Then, cells were rinsed twice with physiological 
saline, rinsed with 5% trichloroacetic acid, dried, and 
placed in a counting vial containing 5 ml of a toluene­
based scintillator liquid containing 0.4% diphenyloxa­
zole (DPO), and 0.01% 1.4­bis­2­(4­methyl­5­pheny­
loxazolyl) benzene (POPOP). The radioactivity was 
measured with a liquid scintillation counter (Beckman 
Instrument, Inc., Irvine, CA).
Detection of EPA or DHA incorporated into 
cells. Cells at the final density of 5 x 105/ml and EPA 
or DHA at 100 μM were mixed in the total volume of 
80 ml in 4 glass tubes (32 mm i.d. x 78 mm). Cells 
were treated at 37 °C or 42 °C for 1 h, and immediately 
centrifuged. After the supernatant was removed, cell 
pellets were suspended in fresh culture medium, trans­
ferred into a centrifuge tube, and then rinsed twice by 
centrifugation at 3000 rpm for 10 min. Supernatant 
was withdrawn with a pipette. The resultant sediment 
was mixed with 0.5 ml chloroform­methanol (2 : 1, by 
volume), homogenized for 2 min, and centrifuged. 
Supernatant containing lipids was transferred into 
another glass tube. The solvent was evaporated in 
atmosphere of nitrogen gas. The extracted lipids were 
separated by a modified method for two­dimensional 
TLC on a silica gel plate and developed with two solvent 
mixtures [2, 13]. The TLC was developed with chlo­
roform­methanol­water (65 : 25 : 4, V : V : V) [14] to 
separate polar lipids, and replaced by the first solvent 
mixture at this time, and nonpolar lipids such as fatty 
acids and triglycerides were separated with petroleum­
ethylether­acetic acid (80 : 18 : 2) [15]. The plate was 
exposed to iodine and lipid fractions were detected. 
Silica gel portions containing fatty acids in the TLC 
plate were shaved, and the powder was transferred 
into a glass tube (5.5 mm i.d. x 200 mm length) sealed 
with cotton in the bottom. Then a mixture of chloro­
form­methanol (1 : 4, V : V) was poured into the tube, 
and the solvent was evaporated. The extracted lipids 
were hydrolyzed, and fatty acids were esterized with 
methanol containing 5% hydrochloride (Wako Pure 
Chemical Co., Japan). Methylesters of EPA and DHA 
were analyzed with a gas chromatograph equipped 
with a flame ionization detector (Shimadzu Seisakusho 
Ltd. Kyoto). The column used was packed with diethyl­
eneglycol succinate (10%, 1 m long). The column 
temperature was retained at 195 °C and the flow rate 
of carrier gas (nitrogen) was 60 ml/min [2].
Statistics. The statistical differences between the 
incorporation rates of [3H]­thymidine in the presence 
and absence of EPA or DHA at the temperatures of 37 °C, 
40 °C, and 42 °C were analyzed using Student’s t­test. 
RESULTS
Inhibitory effect of EPA and DHA on DNA syn-
thesis. DNA synthesis in Ehrlich ascites tumor (EAT) 
cells treated with EPA for 1 h and subsequently cultured 
for 19 h was inhibited in a manner dependent on EPA 
concentrations and treatment temperatures (Fig. 1). 
Upon the treatment with 50 μM EPA at 37 °C, the rate 
of [3H]­thymidine incorporation was inhibited to 63.1 ± 
3.0% (P < 0.001) compared to the control in the ab­
sence of the fatty acids, whilst treatment with 100 and 
150 μM of EPA resulted in the inhibition to 36.7 ± 2.4% 
(P < 0.001) and 16.5 ± 4.3% (P < 0.001), respectively. 
At 40 °C, inhibition of [3H]­thymidine incorporation in 
the absence of fatty acids was not altered compared 
to that at 37 °C, but if 50, 100, and 150 μM of EPA 
were added, the incorporations were inhibited to 
59.9 ± 3.7% (P < 0.001), 29.0% ± 1.9% (P < 0.001), 
and 8.3 ± 1.4% (P < 0.001), respectively. In contrast, 
heat treatment alone at 42 °C inhibited [3H]­thymidine 
incorporation to 57.2 ± 2.7% (P < 0.001) compared to 
control EAT cells at 37 °C. At 42 °C the inhibition of DNA 
synthesis was also enhanced by EPA administration 
(to 41.5 ± 2.0% (P < 0.001), 33.1 ± 1.4% (P < 0.001), 
19.7 ± 1.2% (P < 0.001), and 7.7 ± 0.6% (P < 0.001) for 
25, 50, 100, and 150 μM EPA, respectively). Thus, the 
treatment with EPA at 42 °C resulted in a slightly higher 
inhibition (a 50% inhibitory concentration (IC50), 66 μM) 
of DNA synthesis in tumor cells than that at 37 °C (IC50, 
77 μM), and was similar to that at 40 °C (IC50, 67 μM).
Fig. 1. Inhibitory effect of eicosapentaenoic acid (EPA) on DNA 
synthesis in Ehrlich ascites tumor cells. Cell were treated with 
EPA of indicated concentrations at 37 °C, 40 °C, or 42 °C for 1 h 
and subsequently cultured for 19 h. Cells (1 x 105 cells/ml) were 
then labeled with [3H]­thymidine for 1 h. The incorporations into 
the control (untreated) cells were 40,652 ± 2,356 d.p.m. Values 
represent the mean ± SEM for quadruplicate measurements 
and are shown as a percentage of incorporation in the absence 
of EPA at 37 °C (control) 
Inhibitory effect of DHA on DNA synthesis in EAT 
cells treated in similar manner is shown in Fig. 2. At 37 °C 
DHA inhibited significantly [3H]­thymidine incorporation 
into DNA of EAT cells to 87.9 ± 6.1% (P < 0.05), 32.7 ± 
3.5% (P < 0.001), and 4.1 ± 1.8% (P < 0.001) compared 
to the control at 50, 100, and 150 μM of DHA, respec­
tively. At 40 °C, the incorporation decreased to 67.9 ± 
2.8% (P < 0.001), 19.2% ± 2.1% (P < 0.001), and 0.5 ± 
0.1% (P < 0.001). Based on a decrease in DNA synthesis 
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to 57.2 ± 2.7% (P < 0.001) by hyperthermia alone at 
42 °C, the inhibition rate increased upon combination 
of hyperthermia and DHA administration and yielded 
to 30.7 ± 2.1% (P < 0.001), 10.6 ± 0.9% (P < 0.001), 
and 0.9 ± 0.5% (P < 0.001) for 50, 100, and 150 μM 
DHA, respectively. Thus, a more marked inhibition (IC50, 
55 μM ) of cellular DNA synthesis at 42 °C than that at 
37 °C or 40 °C (IC50, 85 or 69 μM, respectively) was also 
observed for the treatment with DHA. 
Fig. 2. Inhibitory effect of docosahexaenoic acid (DHA) on DNA 
synthesis in Ehrlich ascites tumor cells. Cell were treated with 
DHA at 37 °C, 40 °C, or 42 °C and manipulated in the same manner 
as in Fig. 1. Values represent the mean ± SEM for quadruplicate 
measurements and are shown as a percentage of incorporation 
in the absence of DHA at 37 °C (control) 
Next, DNA synthesis­inhibiting activities of EPA 
and DHA at lower or higher concentrations at three 
temperatures were compared (Fig. 3). The ratio of DNA 
synthesis values in EAT cells treated with DHA versus 
that with EPA under the same treatment conditions 
was calculated from data in Fig. 1 and Fig. 2. Note that 
a DNA synthesis­inhibiting activity of DHA is higher 
at 100 and 150 μM, but lower at 25 and 50 μM than 
that of EPA regardless of temperatures, but is more 
pronounced at higher temperatures.
Fig. 3. Comparison of DNA synthesis­inhibiting activity of EPA 
and DHA at low or high concentrations at 37 °C, 40 °C, or 42 °C. 
The ratio of DNA synthesis values in Ehrlich ascites tumor cells 
treated with DHA versus that with EPA under the same treat­
ment conditions including concentrations and temperatures 
was calculated from data in Fig. 1 and Fig. 2. Note that a DNA 
synthesis­inhibiting activity of DHA is higher at 100 and 150 μM, 
but lower at 25 and 50 μM than that of EPA
Ratio of DNA synthesis in EAT cells exposed to 
EPA or DHA at 42 °C versus that at 37 °C was also 
calculated from data in Fig. 1 and Fig. 2 (Fig. 4). More 
enhanced combined effects of hyperthermia at 42 °C 
were exhibited by DHA than by EPA at the doses higher 
than 50 μM. 
Fig. 4. Hyperthermic enhancement of inhibitory effects of EPA and 
DHA on DNA synthesis. Ratio of DNA synthesis in cells exposed to 
EPA or DHA at 42 °C versus 37 °C was calculated and illustrated
Compared to the above­mentioned treatment of 
EAT cells cultured for 19 h with two polyunsaturated 
fatty acids (PUFA), 5­fold longer culturing of cells upon 
the same treatment resulted in enhanced inhibition of 
DNA synthesis by EPA or DHA. Inhibitory effect of EPA 
or DHA on DNA synthesis in ETA cells treated at 37 °C 
or 42 °C for 1 h and then cultured for 96 h was shown 
in Fig. 5. Incorporation of [3H]­thymidine in the cells 
exposed to 25 and 50 μM EPA at 37 °C decreased to 
78.1 ± 7.1% (P < 0.01) and 0.5 ± 0.1% (P < 0.001) of 
the control level, respectively. Hyperthermia alone at 
42 °C decreased the rate of [3H]­thymidine incorpo­
ration to 87.6 ± 1.8% (P < 0.02) of the control value, 
which was higher than that for the short­term culture 
(57.2%). So, the long­term culturing leads to repair 
from hyperthermic injuries in the absence of EPA or 
DHA. In contrast, the inhibition rates were enhanced 
to 30.0 ± 3.1% (P < 0.001) and 0.6 ± 0.3% (P < 0.001) 
with 25 and 50 μM EPA, respectively. The values of 
[3H]­thymidine incorporation upon addition of 25 and 
50 μM DHA at 37 °C were 80.0 ± 8.0% (P < 0.02) and 
11.3 ± 4.7% (P < 0.001) of the control, respectively, 
whilst at 42 °C they decreased to 46.2 ± 8.2% (P < 
0.001) and 4.5 ± 2.1% (P < 0.001), respectively. Thus, 
the long­term culturing intensified the inhibition of DNA 
synthesis by 50 or 75 μM EPA or DHA at both tem­
peratures, but in contrast restored the DNA synthesis 
inhibition due to hyperthermia alone. It was suggested 
that hyperthermic injuries can be repaired whereas in 
combination with PUFA sublethal additional injuries 
appear which are enhanced to lethal injuries by the 
next long­term culturing.
Relation between the inhibitory activity of 
drugs and their permeation into cells. Incorpora­
tion rates of EPA and DHA into EAT cells have been 
previously measured by TLC and gas­liquid chroma­
tography (GLC) to find a relationship with the cytotoxic 
effects [2]. The fatty acids are incorporated mainly into 
phospholipids (PLs) and triglycerides (TGs) in the cells 
[2, 16–18]. Inhibition of DNA synthesis has been sug­
gested to be due to their free acid forms accumulated 
in the cells as a result of the extracellular supply of 
PUFAs so abundant as to exceed beyond the cellular 
ability to synthesize PLs and TGs [2]. 
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Fig. 5. Inhibitory effect of EPA or DHA on DNA synthesis in Ehrlich 
ascites tumor cells treated at 37 °C or 42 °C for 1 h and further 
cultured for a period as long as 96 h. Cells (1 x 104 cells/ml) were 
then labeled with [3H]­thymidine for 1 h. The incorporations in 
the control (untreated) cells were 210,481 ± 11,015 d.p.m. Values 
represent the mean ± SEM for quadruplicate measurements and 
are shown as a percentage of incorporation in the absence of 
EPA and DHA at 37 °C (control).
In the present study, therefore, contents of EPA and 
DHA in the free fatty acid (FFA) form incorporated into 
the cells exposed to 100 μM of each fatty acid were 
measured. Incorporation of DHA and EPA into lipids of 
cells are shown in thin­layer chromatograms (Fig. 6) and 
the spots of FFA and TG in the cells treated with 25 or 
100 μM EPA or DHA were markedly larger, than these in 
the control cells cultured in the absence of EPA/DHA. 
Fig. 6. Thin­layer chromatograms of lipids extracted from Ehrlich 
ascites tumor cells incubated with docosahexaenoic acid (DHA) 
and eicosapentaenoic acid (EPA). Cells (4 x 107 of total cells) at 
the density of 5 x 105/ml were incubated with 100 μM of DHA or 
EPA at 37 °C or 42 °C for 1 h. Lipids containing the fatty acids 
incorporated into the cells were extracted. Two­dimentional thin­
layer chromatography on a silica gel plate was developed with 
chloroform­methanol­water (65 : 25 : 4, by volume) to separate 
phospholipids and with petroleum ether­ethyl ether­acitic acid 
(82 : 18 : 1) to separate fatty acids, triglycerides etc. The plate 
was exposed to iodine and lipid fractions were detected
Content of DHA and EPA extracted from FFA frac­
tions separated by TLC was quantified by gas­liquid 
chromatography (GLC) (respective gas­liquid chro­
matograms are shown in Fig. 7). Incorporation rate of 
EPA was 0.29% of the total dose and that of DHA was 
0.97% at 37 °C. At 42 °C, the contents of EPA and DHA 
increased to 0.40% and 1.16%, respectively.
Fig. 7. Gas­liquid chromatograms of extracts from lipids of 
Ehrlich ascites tumor cells exposed to EPA and DHA at 37 °C or 
42 °C for 1 h. Fatty acids were extracted from cellular FA fraction 
separated by TLC and hydrolyzed, and fatty acids were esterized 
with methanol containing 5% hydrochloride. Methylesters of EPA 
and DHA were analyzed with a gas chromatograph equipped with 
a column containing diethyleneglycol succinate (10%, 1m long). 
The column temperature was retained at 195 °C and the flow rate 
of carrier gas (nitrogen) was 60 ml/min
Fig. 8. A relation of DNA synthesizing activity and ratio of intracellu­
lar incorporation amount versus dose of EPA or DHA. Cells treated 
with 100 μM of EPA or DHA at 37 °C or 42 °C were incubated in a 
CO2 incubator for 1 h. Intracellular EPA or DHA was extracted and 
quantified by TLC and GLC and evaluated as the ratio versus the 
extracellularly added amount. A correlation of DNA synthesizing 
activity and incorporation were plotted with their values 
DISCUSSION
Cytotoxic or antitumor activity of PUFAs has been 
previously reported [1–6]. The activity depends on the 
length of carbon chain and the number of unsaturated 
bonds, and particularly elevates according to the in­
crease in numbers of double bonds in PUFAs [2, 12]. 
We have reported that EPA and DHA having higher 
number of double bonds, exert stronger inhibition of 
the DNA synthesis in tumor cells than other PUFAs [2]. 
In the present study, furthermore, it was confirmed 
that at lower concentrations DHA inhibits the synthesis 
less markedly than EPA, in contrast to advantages at 
higher concentrations upon the treatment at 37 °C, 
40 °C or 42 °C (Fig. 3). The results are supported with 
a difference of the binding ability of serum albumin 
to EPA and DHA [16], and serum albumin can bind 
more abundant DHA than EPA, whereas DHA is more 
effective than EPA at the lower concentrations un­
der serum free conditions [2]. The unbound drugs 
that are exempted from capture by albumin may be 
subjected to uptake into cells. Then EPA is mainly 
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incorporated into TG [2, 17–19], and DHA to PC within 
the cell. Consequently, they lose cytotoxic activity 
assumedly because of esterification of the terminal 
carboxyl group in the molecule. Administration of the 
large amount of drugs overcomes both their binding 
activity to serum proteins and the cellular ability to 
synthesize the lipids. Thus, free forms of the fatty acids 
are accumulated in the cells and considered to exert a 
cytotoxic action. Intracellular accumulation of free DHA 
is more abundant than that of free EPA (Fig. 6). Their 
accumulation results in cytotoxic effects via produc­
tion of reactive oxygen species (ROS) [20–22], that 
may be furthermore enhanced by combination with 
hyperthermia, and consequently conduct the promo­
tion of cell­killing [23]. 
The present study showed that 50 μM EPA or DHA 
markedly inhibited DNA synthesis in tumor cells cul­
tured for 19 h after the treatment at 37 °C. Hyperther­
mic treatment enhanced the inhibition rate and the rate 
of inhibition of DNA synthesis was enhanced by long 
term culturing, during which a growing amount of the 
free acid form of PUFA is considered to be metabolized 
and then generate more abundant ROS.
A relation between intracellular contents of the free 
acid form of EPA and DHA and their inhibitory effect is 
shown. EPA exhibits higher inhibitory activity in spite of 
a lower content of incorporation in the cells at 37 °C or 
42 °C, whereas ratio of the incorporation content versus 
the inhibitory activity for DHA is nearly 3­fold higher 
than that for EPA. This difference could be probably 
explained by the fact that EPA is more stable in an intra­
cellular space and is less easily metabolized than DHA. 
This is supported by the fact that EPA is more cytotoxic 
than DHA on the long­term culturing conditions. 
Among fatty acids EPA and DHA have the highest 
inhibitory activity against cellular DNA synthesis and such 
activity is significantly enhanced by hyperthermia. The 
inhibition of DNA synthesis is closely related to the viability 
of the cells [2]. Therefore, administration of EPA or DHA 
in combination with hyperthermia could be considered 
as an attractive mean for treatment of cancer.
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ГИПЕРТЕРМИЯ УСИЛИВАЕТ СТЕПЕНЬ ПОДАВЛЕНИЯ СИНТЕЗА 
ДНК ПРИ ОБРАБОТКЕ КЛЕТОК КАРЦИНОМЫ ЭРЛИХА 
ЭЙКОЗОПЕНТАЕНОВОЙ И ДОКОЗАГЕКСАЕНОВОЙ КИСЛОТАМИ 
Цель: исследовать ингибирующее воздействие эйкозопентаеновой кислоты (EPA) и докозагексаеновой кислоты (DHA) 
на синтез ДНК в комбинации с гипертермией в модели in vitro. Методы: суспензию клеток асцитной карциномы Эрлиха 
(EAT) смешивали с DHA или EPA в стеклянной пробирке, инкубировали в течение 1 ч при 37 °C, 40 °C или 42 °C 
в водяной бане и культивировали при 37 °C 19 или 96 ч. Синтез ДНК оценивали по уровню включения [3H]-тимидина. 
DHA или EPA, включившиеся в клетки EAT cells, экстрагировали, а их количество определяли методами тонкослойной 
и газожидкостной хроматографии. Результаты: степень ингибирования синтеза ДНК при действии EPA или DHA 
значительно возрастала при обработке клеток при 42 °C в сравнении с таковым при 37 °C. При 37 °C ингибирующее 
действие EPA было более выраженным, чем таковое DHA в низких концентрациях (при концентрации 50 μM — 63,1 
против 87,9%), а DHA — более сильным при концентрации 150 μM (16,7 vs 4,4%). Эффект DHA в сравнении с EPA 
был более выраженным при 40 °C (29,0 vs 19,2% при концентрации 100 μM) или 42 °C (19,7 vs 10,6% при концентрации 
100 μM). При обработке клеток EPA или DHA с последующим культивированием в течение 96 ч наблюдалось 
усиление ингибирующего воздействия EPA даже при концентрации 50 μM как при 37 °C (0,5 vs 11,3%), так и при 
42 °C (0,6 vs 4,5%), что в таких условиях было значительнее, чем у DHA. В то же время степень включения EPA в 
клетки EAT при 37 °C или 42 °C была ниже, чем таковая DHA. Выводы: введение DHA или EPA in vitro значительно 
ингибирует синтез ДНК, и этот эффект усиливается на фоне комбинированного применения кислот и гипертермии. 
Ключевые слова: эйкозопентаеновая кислота, докозагексаеновая кислота, гипертермия, цитотоксическая активность, 
синтез ДНК.
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